6 recruiting. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 6 |
| Phase 1 | 1 | Recruiting 1 |
Follow Valacyclovir: new trials by email Literature Review of Valacyclovir trials Research Report on Valacyclovir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction Valacyclovir, Celecoxib, Paxlovid - Post-acute Sequelae of COVID-19, Long COVID | Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 150 | 2026-10-20 | 2026-10-28 |
| Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma TGX-007, Valaciclovir - Glioblastoma (GBM), High Grade Gliomas | Phase 1 / Phase 2 | Recruiting | Trogenix ltd | 68 | 2026-04-21 | 2026-10-23 |
| A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec aglatimagene besadenovec + valacyclovir, External Beam Radiation Therapy (EBRT) - Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma) | Phase 2 | Recruiting | Candel Therapeutics, Inc. | 45 | 2025-10-30 | 2026-09-15 |
| Valacyclovir in Pain Management of Acute Apical Abscesses Valacyclovir 500 MG, Placebo - Acute Apical Abscess, Pain, Acute | Phase 2 | Recruiting | University of California, San Francisco | 60 | 2023-10-25 | 2025-05-30 |
| Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT) Pirtobrutinib, Obinutuzumab, Venetoclax - Leukemia | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 60 | 2022-12-20 | 2026-04-30 |
| Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery HSV-Tk, Valacyclovir, Bicalutamide - High-risk Prostate Cancer, Prostate Cancer | Phase 2 | Recruiting | The Methodist Hospital Research Institute | 60 | 2018-08-02 | 2021-04-06 |
Prostatic Neoplasms (2) · Acute Pain (1) · Adenocarcinoma (1) · Glioblastoma (1) · Leukemia (1) · Post-Acute COVID-19 Syndrome (1)
Candel Therapeutics, Inc. (1) · Icahn School of Medicine at Mount Sinai (1) · M.D. Anderson Cancer Center (1) · The Methodist Hospital Research Institute (1) · Trogenix ltd (1) · University of California, San Francisco (1)
United States (6) · United Kingdom (1)
David Putrino, PhD (1) · E. Brian Butler, MD (1) · Mike Sabeti, DDS (1) · Nitin Jain, MD (1)